San Francisco-based ZBiotics, a company specializing in genetically engineered probiotics, has raised $12 million in a Series A funding round led by Spring Tide Capital. The funds will be used to expand ZBiotics’ retail presence and develop new products beyond their initial offering—a probiotic designed to reduce hangover symptoms by breaking down acetaldehyde in the gut. The company is proud of its GMO label and plans to launch more gut-health products soon while exploring other health areas like sleep and athletic performance.
ZBiotics raises $12m Series A for its ‘proudly GMO’ probiotics targeting gut health, hangovers and more (AgFunderNews)
0